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606Multimodality Imaging of AortitisMultimodality imaging of aortitis is useful for identiﬁcation of acute and chronic mural changes due to inﬂammation,
edema, and ﬁbrosis, as well as characterization of structural luminal changes including aneurysm and stenosis or
occlusion. Identiﬁcation of related complications such as dissection, hematoma, ulceration, rupture, and thrombosis is
also important. Imaging is often vital for obtaining speciﬁc diagnoses (i.e., Takayasu arteritis) or is used adjunctively in
atypical cases (i.e., giant cell arteritis). The extent of disease is established at baseline, with associated therapeutic and
prognostic implications. Imaging of aortitis may be useful for screening, routine follow up, and evaluation of
treatment response in certain clinical settings. Localization of disease activity and structural abnormality is useful for
guiding biopsy or surgical revascularization or repair. In this review, we discuss the available imaging modalities for
diagnosis and management of the spectrum of aortitis disorders that cardiovascular physicians should be familiar with
for facilitating optimal patient care. (J Am Coll Cardiol Img 2014;7:605–19) ª 2014 by the American College of























Idiopathic retroperitoneal ﬁbrosis (periaortitis)
Radiation-induced aortitis
Infectious aortitis
Bacterial (e.g., Salmonella or Staphylococcus)
Luetic (syphilis)
Mycobacterial (e.g., Mycobacterium tuberculosis or Nocardia)
Viral (e.g., hepatitis B, hepatitis C, and human immunodeﬁciency
virus)
ANCA ¼ anti-neutrophil cytoplasmic antibody.Aortitis is a pathologic term for the presence of
inﬂammatory changes of the aortic wall. Aortic wall
inﬂammation may be of infectious etiology, but is
more commonly of noninfectious origin (1). The
classiﬁcation of aortitis and clinical ﬁndings of
conditions frequently associated with aortitis can be
found in Tables 1 and 2. Patients with noninfec-
tious aortitis related to large-vessel vasculitis may
present with symptoms of arterial insufﬁciency in
the case of Takayasu arteritis or a characteristic
headache with giant cell arteritis. Incidental vas-
cular ﬁndings may be identiﬁed in patients pre-
senting with a rash or arthralgias suggestive of
collagen vascular disorders, such as rheumatoid
arthritis, systemic lupus erythematous, and anky-
losing spondylitis. Not uncommonly, aortitis is an
unsuspected ﬁnding in patients being evaluated for
unexplained fever or chest, abdominal, or back
pain. Infectious aortitis is associated with various
bacterial and viral pathogens, and patients may
present with classic risk factors such as exposure
history, high-risk behavior, immunosuppression,
and recent surgical instrumentation. Both clinical
and imaging features, including the pattern of
aortic involvement, help distinguish between non-
infectious and infectious causes. There is signiﬁcant
overlap of imaging characteristics among aortitis
etiologies, and the importance of integrating the
entire clinical picture with imaging ﬁndings cannot
be overstated.
Imaging Aortitis
Multiple imaging modalities are used in the
evaluation of both inﬂammatory and noninﬂam-
matory aortic diseases (2). Nuclear imaging with
Figure 1. Positron Emission Tomography Imaging of
Giant Cell Aortitis
(A) Coronal and (B) sagittal views with localizing noncontrast
computed tomography (C) demonstrate intense tracer uptake
(arrows) localized to the abdominal aorta.
A B B R E V I A T I O N S
A N D A C R O N YM S
CT = computed tomography
CTA = computed tomography
angiography
MPR = multiplanar reformatting
MR = magnetic resonance
MRA = magnetic resonance
angiography
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607ﬂuorine-18-ﬂuorodeoxyglucose positron emission to-
mography (PET) is helpful in assessment of inﬂam-
matory activity. Multidetector computed tomography
(CT) has excellent spatial resolution and is commonly
the imaging modality of choice when aortic pathology
is present. Multidetector scanners allow multiplanar
reformation and 3-dimensional reconstruction, thus
allowing evaluation of both arterial wall changes and
abnormalities of the aortic lumen. Cardiovascular
magnetic resonance (MR) imaging similarly allows
excellent visualization of the arterial wall and vascular
lumen, with multiplanar and 3-dimensional refor-
mation. Transthoracic echocardiography (TTE) isin general the ﬁrst modality used for ascending aorta
and aortic valve assessment. It provides structural
and functional information about the aortic valve
and anatomical characterization of the aortic root
and ascending aorta (i.e. wall thickness and di-
mensions). Transesophageal echocardiography
(TEE) can image both the ascending and des-
cending thoracic aorta and provides superior spatial
resolution compared to TTE. TEE is useful for
the assessment of aortic mural complications
and pre-operative, post-operative, and perioperative
evaluation.
Positron Emission Tomography
Aortitis is associated with inﬂammatory cell inﬁltra-
tion of the media and/or periaorta caused by a variety
of immunologic, infectious, or traumatic factors.
PET utilizes the metabolic accumulation
of ﬂuorine-18-ﬂuorodeoxyglucose in the
inﬂammatory milieu, mostly in monocytes.
Fluorine-18-ﬂuorodeoxyglucose does not
accumulate in normal vascular structures;
therefore, any uptake in the aorta is con-
sidered abnormal. Generally, uptake is
considered signiﬁcant when aortic signal is
signiﬁcantly more intense than that of the
liver (3) (Fig. 1). Uptake can be seen in
atheromas and vulnerable plaque, with
focal uptake generally due to atheromata.
Due to the simplicity of PET interpreta-
tion, no speciﬁc protocols are needed (4).
Although the spatial resolution of PET is
limited and provides little anatomic char-
acterization, when combined with com-
puted tomography angiography (CTA) or
magnetic resonance angiography (MRA), the sen-
sitivity and speciﬁcity is improved due to further
delineation of mural and luminal abnormalities and
more precise anatomical localization (5). Importantly,
initial avid ﬂuorine-18-ﬂuorodeoxyglucose uptake
has been reported to normalize with appropriate ste-
roid or antimicrobial therapy for a variety of inﬂam-
matory and infectious aortitis causes (6–13).
PET was ﬁrst utilized for imaging aortitis in the
late 1990s to help establish a diagnosis in patients
with fever of unknown origin. Giant cell arteritis
with atypical (extracranial) features and Takayasu
arteritis in the early “pre-pulseless” phase was often
diagnosed in these patients (14,15). Numerous
studies have since demonstrated the utility of PET
in giant cell arteritis patients (16) given that tem-
poral artery biopsy is negative in about 15% of
typical giant cell arteritis patients and approximately
Table 2. Clinical Findings of Conditions Frequently Associated With Aortitis
Giant cell arteritis
Patients are generally age 65 years and older. The temporal artery is classically involved, and patients may have a characteristic headache
with scalp tenderness, jaw claudication, and visual disturbancesdpotentially causing permanent blindness. One-half of patients may
have coexistent polymyalgia rheumatica. Aortitis may involve the aortic root, causing ostial coronary stenoses and/or valvulitis with aortic
insufﬁciency. Useful aortitis imaging modalities: PET, CT/CTA, coronary CTA, vascular MR/MRA, cine and phase contrast cardiac MR,
and TTE.
Takayasu arteritis
Typically affects patients (women more than men) <50 years of age. An initial “inﬂammatory phase” with nonspeciﬁc systemic symptoms
such as weight loss and fatigue is followed by a “pulseless phase” affecting the aorta and branch vessels, potentially causing syncope or
stroke-like symptoms (carotid arteries), extremity claudication (subclavian or iliac arteries), or refractory hypertension (renal arteries).
Ostial coronary stenoses may cause angina. Pulmonary vasculature may be involved as well. Useful aortitis imaging modalities: PET,
CT/CTA, coronary CTA, vascular MR/MRA, cine and phase contrast cardiac MR, TTE, and vascular ultrasound.
HLA B27–associated spondyloarthropathies
Generally affects young men and women (age 20 to 40 years). Patients often have progressive arthralgias related to spondylitis and
sacroiliitis. Uveitis may be present in ankylosing spondylitis, and is common in Reiter syndrome, as is urethritis or cervicitis. Aortitis may
involve the aortic root, causing valvulitis and aortic insufﬁciency. Useful aortitis imaging modalities: PET, CT/CTA, coronary CTA, vascular
MR/MRA, cine and phase contrast cardiac MR, and TTE.
Immunoglobulin G4–related aortitis
Fibrosclerotic aortitis with dense lymphocytoplasmic inﬁltration of the thoracic and/or abdominal aorta, particularly prone to dissection.
Serum immunoglobulin G4 levels are not consistently elevated. May be associated with retroperitoneal ﬁbrosis, as well as involvement of
other retroperitoneal organs (pancreas and kidney) and distant organs (salivary glands). Epidemiology is not well characterized. Aortitis
may involve the aortic root, causing ostial coronary stenoses and/or valvulitis with aortic insufﬁciency. Useful aortitis imaging modalities:
PET, CT/CTA, coronary CTA, vascular MR/MRA, cine and phase contrast cardiac MR, and TTE.
Behcet’s disease
Generally affects young men and women (age 20 to 40 years). Patients commonly have painful oral and genital ulcerations and visual
disturbances due to various forms of ocular inﬂammation. Venous involvement is more common than arterial; however, saccular
aneurysms, pseudoaneurysms, occlusion, and thrombosis of the aorta and pulmonary arteries are possible. Aortitis may involve the aortic
root, causing ostial coronary stenoses and valvulitis with aortic insufﬁciency. Useful aortitis imaging modalities: PET, CT/CTA, coronary
CTA, vascular MR/MRA, cine and phase contrast cardiac MR, and TTE.
Cogan’s syndrome
Generally affects young men and women (age 20 to 40 years). Symptoms include visual disturbances, dizziness, and hearing impairment
due to ocular and inner ear inﬂammation. Aortitis may involve the aortic root, causing ostial coronary stenoses and/or valvulitis with
aortic insufﬁciency. Useful aortitis imaging modalities: PET, CT/CTA, coronary CTA, vascular MR/MRA, cine and phase contrast cardiac MR,
and TTE.
Relapsing polychondritis
Typically affects men and women age 40 to 60 years. Symptoms may include painful, erythematous swelling of the ears, nose, joints, and
other cartilaginous structures due to inﬂammation of cartilage. Aortitis may involve the aortic root and ﬁbrous cardiac skeleton, causing
aortic and mitral valvulitis with associated valvular insufﬁciency. Useful aortitis imaging modalities: CT/CTA, coronary CTA, vascular
MR/MRA, cine and phase contrast cardiac MR, and TTE.
Idiopathic aortitides
Generally affects male patients >55 years of age. Patients typically do not have systemic disease; rather, symptoms such as back pain and
ureteral entrapment with hydronephrosis are related to the mass effect of periaortic ﬁbrosis and adhesions in adjacent retroperitoneal
structures of the abdomen and pelvis. The thoracic aorta is rarely involved. Biopsy may be required to differentiate periaortic ﬁbrosis from
malignant or infectious etiology. Useful aortitis imaging modalities: PET, CT/CTA, vascular MR/MRA, and abdominal ultrasound.
CT ¼ computed tomography; CTA ¼ computed tomography angiography; MR ¼ magnetic resonance; MRA ¼ magnetic resonance angiography; PET ¼ positron
emission tomography; TEE ¼ transesophageal echocardiogram; TTE ¼ transthoracic echocardiogram.
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60840% of those with predominantly large vessel in-
volvement (17). Giant cell arteritis has now been
established as the most common form of aortitis
(18). Furthermore, about 30% of polymyalgia
rheumatica (often coexistent with giant cell arteritis)
patients have demonstrated large vessel arteritis,
including aortitis (19). The sensitivity and speci-
ﬁcity of PET in diagnosing giant cell arteritis
or polymyalgia rheumatica are reported as 80%
and 89%, respectively, in a recent meta-analysis;
however, these results must be interpreted with
caution due to admittedly nonstandardized PETinterpretation methodologies, inhomogeneous re-
ference standards, and inconsistent use of PET/
computed tomography (CT) (20). Although PET
ﬁndings normalize during steroid therapy in accor-
dance with clinical ﬁndings and inﬂammatory
markers such as erythrocyte sedimentation rate and
C-reactive protein, there is no data to support
routine follow-up PET imaging to monitor treat-
ment response or predict risk of relapse (21). How-
ever, ﬁndings suggest that PET may be useful when
clinical concern exists for relapse or steroid refractory
disease that may beneﬁt from cytotoxic or biological
Figure 2. CTA of Takayasu Aortitis With Various Reformatting
Methods
(A) Coronal volume rendered image showing stenosis of the distal
abdominal aorta and occlusion of the right renal artery (green
arrow) with infrarenal abdominal aortic aneurysm (pink arrow).
(B) Sagittal maximum intensity projection image demonstrating
patency of the stenosed and densely-calciﬁed abdominal aorta
and multiple collaterals ﬁlling the iliac vessels (yellow arrows).
(C) Oblique multiplanar reformatted image demonstrating aneu-
rysmal ascending aorta (AAo) (measuring 4.5 cm) and mild luminal
narrowing of the aortic arch (blue arrow). CTA ¼ computed to-
mography angiography.
Figure 3. Differentiation of Aortitis From Intramural Hematoma
Aortitis on (A) noncontrast computed tomography (CT) demonstrating low
attenuation of the thickened aortic wall (w34 Hounsﬁeld units [HU]) and
(B) computed tomography angiography (CTA) demonstrating enhancement of
the thickened aortic wall (w72 HU) after contrast administration. Intramural
hematoma on (C) noncontrast CT demonstrating higher attenuation (w50 HU)
of clot and (D) CTA demonstrating intimal disruption and subintimal calcium
displacement. (E) Aortitis on T1-weighted magnetic resonance (MR) imaging
demonstrating hypointensity of the thickened aortic wall (yellow arrow).
(F) Intramural hematoma on T1-weighted MR imaging demonstrating increased
signal intensity of clot (pink arrow) compared to aortic wall. The green circles
are the regions of interest for attenuation value sampling (to determine HU).
Ao ¼ aorta.
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609therapy (22). Interestingly, PET ﬁndings at baseline
predict risk of later aortic dilation and may identify
patients who are at increased aortic aneurysm risk
and who would beneﬁt from follow-up imaging (23).
PET is useful in the diagnosis of Takayasu
arteritis, potentially in the “pre-pulseless” phase
(24). This provides an important window of op-
portunity to therapeutically intervene prior to the
overtly symptomatic and highly morbid “pulseless”
phase, which is characterized by severe large vessel
stenosis and occlusion (25). The reported ranges of
sensitivities and speciﬁcities for PET in diagnosing
Takayasu arteritis are 69% to 93% and 33% to
100%, respectively, in these generally small studies
with highly-variable methodologies (21,26). Like
giant cell arteritis patients, effective therapy is
associated with activity normalization on PET;
however, Takayasu arteritis patients experience
excess rates of relapse (up to 50%), despite previ-
ously effective steroid therapy (21,25). PET may be
useful for routine monitoring of treatment response,
as it has been found to be superior to erythrocytesedimentation rate and C-reactive protein in iden-
tifying patients relapsing on steroids, as these pa-
tients may beneﬁt from cytotoxic or biological
therapy (21,26). Furthermore, documentation of
remission is a prerequisite for revascularization, as
surgical revascularization during the active phase of
Takayasu arteritis is associated with high rates of
graft failure and progression of symptomatic disease
at other sites (27).
PET may be useful for characterization of idio-
pathic aortitis and its variants, including chronic
periaortitis, idiopathic inﬂammatory aortic aneu-
rysm, and retroperitoneal ﬁbrosis (28). PET may
demonstrate periaortic activity and characterize the
extent of activity (21). Combination of PET with
CTA or MRA is vital for localizing activity to the
periaorta, with associated diagnostic and therapeutic
implications (29,30). PET may also identify addi-
tional remote sites of ﬂuorine-18-ﬂuorodeoxyglucose
uptake suggestive of occult malignancy or infection,
and may be useful for identiﬁcation of treatment
relapse (21,28).
Figure 4. Cardiac CTA of Takayasu Aortitis
Multiplanar reformatted images demonstrating (A) dense aortic root (AoR) calciﬁ-
cationanddilatedascendingaorta (AAo) (measuring4.0 cm), (B)dense calciﬁcation
of the left main coronary artery and signiﬁcant ostial stenosis (pink arrow). CTA¼
computed tomography angiography; MPA ¼main pulmonary artery; LA¼ left
atrium; LV¼ left ventricle; RPA ¼ right pulmonary artery; RV¼ right ventricle.
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610Computed Tomography
Both CT and CTA are particularly attractive for
imaging aortitis and branch vessel arteritis due to
unparalleled spatial resolution and scan time gener-
ally <1 min, requiring only a single breath hold. CT
imaging characterizes mural thickening (i.e., >2 to
3 mm is considered diagnostic for aortitis, distribu-
tions differ by etiology) and inﬂammatory periaortic
soft tissue changes, such as fat stranding. CTA
affords excellent vessel to background distinction to
facilitate comprehensive assessment of both luminal
and mural anatomy (16,22,31). Various 3D recon-
struction methods including maximum intensity
projection, multiplanar reformatting (MPR), andFigure 5. Coronary CTA of Giant Cell Aortitis
The right coronary artery is narrowed as it courses through a thick AoR
multiplanar reformatted images. RA¼ right atrium; RV¼ right ventricle; RVvolume rendering complement the standard se-
quential axial views (32) (Fig. 2). Maximum in-
tensity projection and MPR can render an
“angiographic” view suitable for measurement of
luminal caliber and characterization of ectasia, dila-
tion, stenosis, and occlusion of the aorta and its
branches. Axial CTA, MPR, and volume rendering
provide detailed mural characterization including
extent of thickening and presence of layering
thrombus, as well as identiﬁcation of hazardous
mimics of aortitis, such as intramural hematoma
and penetrating ulcer, which appear as eccentric
crescent-shaped or circumferential thickening with
potential intimal or subintimal disruption on con-
trast imaging (32,33). Pre- and post-contrast im-
aging can help differentiate aortitis from intramural
hematoma, as aortitis will have low attenuation (i.e.,
<40 Hounsﬁeld units) on pre-contrast images with
post-contrast enhancement, whereas intramural
hematoma will have higher attenuation (i.e., >50
Hounsﬁeld units) on both pre- and post-contrast
imaging (Figs. 3A to 3D). CTA has also been
used to identify complications of advanced aortitis,
such as saccular aneurysm, pseudoaneurysm, and
thrombosis, in a variety of inﬂammatory conditions
(34–39). CTA is also useful in guiding revasculari-
zation in those with arterial insufﬁciency of
branch vessels causing claudication, cerebrovascular
ischemia, intestinal angina, renal failure, or refrac-
tory hypertension. Electrocardiogram-gated cardiac
CTA may be useful for characterizing aortic root
and anatomic aortic valvular abnormalities (40,41)
(Fig. 4). Coronary CTA readily identiﬁes aortitis-
associated ostial and proximal coronary stenosis
(Fig. 5) and may be used as a guide for revasculari-
zation (5,42).wall (pink arrows); demonstrated on (A) axial and (B and C)
OT¼ right ventricular outﬂow tract; other abbreviations as in Figure 4.
Figure 6. CTA of Takayasu Aortitis
Axial slices show increased wall thickness (arrows) in the AAo
and the descending aorta (DAo) (A), the aortic arch (AoA) (B), and
the branch vessels of the arch (C). There is a “double ring”
appearance due to an enhancing outer ring of inﬂamed media and
adventitia surrounding poorly enhanced edematous intima
(typical of early disease). Abbreviations as in Figure 4.
Figure 7. CTA of Takayasu Aortitis
(A) Volume rendered image demonstrates eccentricity of the AoA and
multiplanar reformatted images demonstrate that eccentricity is due to
appearance (yellow arrows) without signiﬁcant luminal dilation. Abbre
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611Serial CT and CTA may be used in screening for
aneurysm development in high-risk patients and in
routine monitoring of established aneurysms to
accommodate timely surgical management to treat
those at high risk for rupture (i.e., diameter of 5 cm
in aortic root, 6 cm in the thoracic aorta, or 5.5 cm
in the abdominal aorta, or expansion of any site by
$0.5 cm in a 6-month period) (33). The drawbacks
of CT and CTA are inferior characterization of
disease activity and mural inﬂammation, notably
in early phases; ionizing radiation; and iodinated
contrast media in the case of CTA.
Noninvasive angiographic imaging, such as CTA,
has become the cornerstone of diagnosis for Takayasu
arteritis in patients presenting with bruits, pulse
deﬁcits, or symptoms of vascular insufﬁciency in the
characteristic clinical setting (25). These patients
often have advanced structural aortic and branch
arterial disease. A “double ring” appearance on post-
contrast images due to a brightly enhanced outer ring
of inﬂamed media and adventitia surrounding
poorly enhanced edematous intima is typical of early
Takayasu aortitis (2) (Figs. 6 and 7). Structural
ﬁndings, such as aneurysm and stenosis of the aorta or
branch vessels, has a speciﬁcity and sensitivity of 95%
and 100%, respectively, for the diagnosis of late-stage
disease (43). Signiﬁcant aortic aneurysms are found in
up to 45% of patients, with up to 33% of these
rupturing if left untreated. Pulmonary arteritis with
resultant aneurysm formation and/or stenosis may be
found in about 15% of patients (44).
Extracranial giant cell arteritis is the most com-
mon etiology of aortitis. CT ﬁndings of aortitisproximal branch vessels (green arrow). (B) Sagittal and (C) coronal
thickened aortic and branch vessel walls with a “double ring”
viations as in Figure 4.
Figure 8. CTA of Giant Cell Aortitis
(A) Coronal multiplanar reformatted image demonstrates diffuse thickening of
the thoracic and abdominal aorta (Ao). (B and C) Off-axis maximum intensity
projection images of the left subclavian artery showing smooth tapering
extending distally (yellow arrows). CTA ¼ computed tomography
angiography.
Figure 9. CTA of Immunoglobulin G4 Aortitis
(A) Volume rendered image demonstrates eccentric AAo (pink arrow) with
patent abdominal aorta and branch vessels. (B to D) Multiplanar reformatted
images of the AAo in 3 different planes showing undulating wall thickening
and saccular aneurysm (maximal diameter of 4.3 cm). Ao ¼ aorta; other
abbreviations as in Figure 4.
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612are found in >50% of those with a new giant cell
arteritis diagnosis, including mural thickening in
>40% and frank aneurysm in up to 15% (16). A
characteristic ﬁnding of giant cell aortitis is long
segment thickening with smooth distal tapering,
more commonly found in the descending aorta and
subclavian arteries (Fig. 8) (5,45). Annuloaortic
ectasia and ascending aortic dilation and aneurysm
are not uncommon, and may be a result of localized
inﬂammatory activity or functional coarctation of
the thickened descending aorta resulting in
elevated pressures in the thoracic aorta (16,46).
Serial noncontrast chest CT may be considered
for routine thoracic aortic aneurysm screening and
follow-up in giant cell aortitis patients due to
increased risk and associated morbidity and mor-
tality if undetected and untreated, although this
strategy does carry signiﬁcant radiation exposure,
most notably for those diagnosed at younger
ages (22).
Immunoglobulin G4–related aortitis is a recently
described entity possessing signiﬁcant overlap with
other aortitides, often demonstrating aortic wall
thickening, aneurysm formation, and dense peri-
aortic ﬁbrosis on CTA (47). Unlike the classic
idiopathic aortitis spectrum, which primarily affects
the abdominal aorta, immunoglobulin G4–related
aortitis may involve the abdominal aorta and the
thoracic aorta and its branches (48) (Fig. 9), with
dense periarterial plaques described on coronary
CTA (49). Immunoglobulin G4–related aortitis is
particularly aggressive, with aortic dissection present
in nearly one-half of the affected patients in a
recently reported series (50).
Idiopathic aortitis and its variants, including
chronic periaortitis, idiopathic inﬂammatory aortic
aneurysm, and retroperitoneal ﬁbrosis, generally
affect the abdominal aorta and are all well charac-
terized by CT. Common ﬁndings of chronic peri-
aortitis include irregular aortic thickening with
dense adhesions. CTA will reveal a concentric en-
hanced soft tissue mass surrounding the aorta,
often causing signiﬁcant stenosis of the aorta and
branches (44). Idiopathic inﬂammatory aortic
aneurysm appears fusiform on CTA, with a dense
perianeurysmal ﬁbrotic thickening, often sparing
the posterior wall, and occasionally extending to
other retroperitoneal structures (51). The periaortic
location of thickening with associated luminal
ﬁndings is pathognomonic, which facilitates early
diagnosis and precludes tissue biopsy in classic
cases to afford prompt systemic steroid therapy,
which may prevent luminal narrowing, aneurysm
formation, and progressive retroperitoneal ﬁbrosis
Figure 10. CTA of Infectious Aortitis
Axial slice in a patient with nocardia aortitis post-coronary bypass
grafting demonstrates a large thick-walled aneurysm of the mid-
AAo measuring 8.1  6.9 cm (pink arrow). Abbreviations as in
Figure 4.
Figure 11. Cardiovascular Magnetic Resonance of
Takayasu Aortitis
Post-contrast images demonstrating aortic wall thickening and
enhancement with a “double ring” appearance (pink arrows).
(A) Axial view of descending thoracic aorta. (B and C) Multiplanar
reformatted coronal views of aortic arch.
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613(28). Occasionally, the diagnosis is incidentally
made on surgical histopathology in unsuspecting
patients who have undergone aneurysm repair. The
hallmark of periaortic retroperitoneal ﬁbrosis is a
dense homogenous soft tissue plaque surrounding
the abdominal aorta often enveloping, but not
displacing, adjacent features such as the inferior
vena cava and the ureters, and may cause resultant
lower extremity venous stasis and ureteral ob-
struction with resultant renal failure; contrast
enhancement varies depending on activity (52).
Patients with idiopathic aortitis and variants should
undergo routine thoracic and abdominal aortic
screening due to the risk of recurrent aneurysm,
even in other vascular beds (44).
CT readily identiﬁes complications of infectious
aortitis, and detection of mycotic aneurysms is
particularly important due to the risk of fatal
rupture in excess of 75% if left untreated. Mycotic
aneurysms appear as saccular or lobulated peri-
aortic masses with ﬂuid and gas collections (53)
(Fig. 10). Aortic graft infections have ﬁndings
similar to mycotic aneurysms in the perigraft tis-
sue, and may be associated with pseudoaneurysm
or aortoenteric ﬁstulae (54). Syphilitic aortitis
demonstrates diffuse thickening, often with 1 or
more aneurysms, occasionally with mural thrombi.
Tuberculous aortitis is characterized by focal
irregular mural thickening, with multiple, often
saccular, pseudoaneurysms; a periaortic mass may
be present (44). Both syphilitic and tuberculous
aortitis may mimic Takayasu aortitis; syphilitic
aortitis may demonstrate a characteristic “double-
ring” (5,44).Cardiovascular MR
Cardiovascular MR, like CT and CTA, renders
multiplanar images and provides 3D reconstruction
capabilities in aortitis imaging. Although its spatial
resolution is inferior to CT and CTA, MR has
superior soft tissue characterization due to multiple
dedicated sequence protocols. In addition to iden-
tifying mural thickening, MR characterizes mural
edema with T2 “edema weighted” sequences, and
gadolinium contrast-enhanced MR identiﬁes mural
ﬁbrosis; like PET, both potentially yield important
information regarding disease activity prior to
development of luminal changes (55,56) (Fig. 11).
Figure 12. Magnetic Resonance Angiography of Aortitis
Maximum intensity projection images of the thoracic and abdominal aorta.
(A) Takayasu aortitis with severe distal abdominal aortic stenosis (green
arrow) and collaterals from the renal and mesenteric circulation (pink arrows)
supplying the distal aorta and iliac circulation. (B) Immunoglobulin G4 aortitis
with irregular descending aortic contour and ostial occlusion of the celiac trunk
(yellow arrow) with collaterals from the mesenteric circulation (blue arrow).
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614MRA provides luminal information, including
vessel stenosis, dilation, and thrombosis, compara-
ble to that of CTA but without the need for iodin-
ated contrast or ionizing radiation (Fig. 12). MRA
may utilize either gadolinium contrast-enhanced
or noncontrast protocols, which may allay concerns
in those with signiﬁcant renal dysfunction. Coro-
nary MRA is less sensitive than coronary CTA;Figure 13. Cardiac Magnetic Resonance of Immunoglobulin G4 Aor
(A) Short-axis cine of aortic valve in mid-diastole shows a trileaﬂet valve w
outﬂow tract view cine in mid-diastole demonstrating signiﬁcant aortic
(pink arrow). (C) Phase contrast magnetic resonance (same orientation
arrow). The measured regurgitant fraction was 49%. Ao ¼ aorta.however, it may be useful in identifying ostial or
proximal coronary involvement in aortitis (57). Due
to superior soft tissue characterization, MR may
be the best test to identify and exclude aortitis
mimics and complications such as aortic dissection,
penetrating ulcer, and intramural hematoma (58)
(Figs. 3E and 3F). Similar to CT and CTA, MR
may be used for screening of aneurysm development
and routine monitoring of established aneurysms,
and it is useful in guiding revascularization (2).
The drawbacks of MR, in addition to a lower
spatial resolution than CT and CTA, include scan
times that are often in excess of 45 min requiring
multiple breath holds; artifacts and safety concerns
related to implanted cardiovascular devices; and
limitations of MRA including overestimation of
the degree of branch point stenoses, poor perfor-
mance in distal branches, and suboptimal visuali-
zation of calcium.
Although MR/MRA is comparable to CT/CTA
in the structural characterization of inﬂammatory
and infectious aortitis, an added beneﬁt of MR is
the option to perform cardiac sequences demon-
strating endocardial, myocardial, and pericardial
complications related to aortitis, in addition to the
assessment of aortic root and valve morphology.
Cine and phase-contrast MR are the gold standards
for evaluation of myocardial function and aortic
regurgitation (56). This is particularly relevant as
aortic root inﬂammation and dilation, valvulitis, and
aortic valve insufﬁciency have been described in both
infectious and noninfectious aortitis (2,44) (Fig. 13).
Relapsing polychondritis is also associated with
signiﬁcant mitral valve regurgitation that can betitis
ith central noncoaptation due to annular dilation. (B) Left ventricular
root dilation (4.3 cm at the sinus of Valsalva) and aortic regurgitation
as B) showing signiﬁcant regurgitant ﬂow in mid-diastole (pink
Figure 14. Carotid Ultrasound of Takayasu Arteritis
(A and B) Grayscale and (C and D) color Doppler imaging of the common
carotid artery. Short-axis views (A and C) demonstrate increased concentric
vascular thickness with a bright halo. The long-axis views (B and D) demon-
strate the heterogeneous intimal thickening with irregular luminal contour
known as the “macaroni” sign.
Figure 15. TTE of Takayasu Aortitis
Parasternal long-axis (A and B) and short-axis (C and D) views, without and
with color Doppler, demonstrate increased ascending aortic wall thickness with
aortic root diameter of 4.8 cm and a tricuspid aortic valve (AV) with moderate
to severe aortic regurgitation. Ao ¼ aorta; TTE ¼ transthoracic echocardiog-
raphy; other abbreviations as in Figure 4.
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615characterized and quantiﬁed by cardiac MR (2,5).
Cardiac Behcet’s disease may manifest as ventricular
aneurysm or pseudoaneurysm, intracardiac thrombi,
and inﬂammatory endocardial or myocardial ﬁ-
brosis that can be characterized by standard cine,
pre-contrast T1- and T2-weighted, and delayed
contrast-enhanced sequences, respectively (34,56).
Ankylosing spondylitis may be associated with
subaortic ﬁbrosis identiﬁable on delayed contrast-
enhancement cardiac MR, potentially extending
into the cardiac conduction system and causing
heart block (59,60).
Mandatory angiographic evidence of disease ren-
ders MR an indispensable component of Takayasu
arteritis diagnosis, follow-up, and identiﬁcation of
relapse, particularly in the characteristically young
afﬂicted population, in which cumulative ionizing
radiation doses related to CT or PET may be a
concern (25). Extensive thoracic and abdominal
aortic and branch vessel imaging is recommended,
and performance is comparable to CTA and con-
ventional angiography for identiﬁcation of aortic,
branch vessel, and pulmonary artery involvement
(MRA sensitivity and speciﬁcity reported at 100%
for diagnosing late stage disease) (55,56,61). Mural
edema and ﬁbrosis identiﬁed by MR are useful for
early diagnosis and management, although MR is
not as sensitive as PET in the earliest stages of
Takayasu arteritis, in which visualized inﬂammation
may presage edema and ﬁbrosis (62).
The diagnosis of aortitis related to extracranial
giant cell arteritis beneﬁts fromMR identiﬁcation of
mural changes reﬂecting early inﬂammatory
changes, as in Takayasu arteritis. The angiographic
ﬁndings on MRA are analogous to that of CTA and
may be used similarly for serial screening and
follow-up in giant cell aortitis patients at high risk
for aneurysm development or with a diagnosis of
aneurysm (2,63). Like PET, MR has no role for
routine monitoring of disease activity but may be
useful in identifying relapse of extracranial giant cell
arteritis in suspected cases (22). Interestingly, unlike
PET or CT, MR imaging of the temporal arteries
may be useful for the diagnosis of classic cranial
giant cell arteritis by demonstrating temporal artery
mural thickening, luminal narrowing, and mural
gadolinium uptake (16).
Idiopathic aortitis and its variants are also well
characterized by MR. In addition to characteristic
mural and luminal ﬁndings similar to that of CTA,
periaortitis appears to be hypointense on T1-
weighted images and hyperintense on T2-weighted
images. Periaortic ﬁbrosis intensely enhances on
contrast-enhanced MR (28). The dense plaques ofretroperitoneal ﬁbrosis appear hypointense on both
T1- and T2-weighted images in the chronic phase,
although the T2 signal may vary depending on the
level of activity and edema (52). Regarding nonin-
vasive angiography, contrast-enhanced and, perhaps
even more so, noncontrast MRA are likely favorable
Figure 16. TEE of Takayasu Aortitis
Mid-esophageal views of the aortic root (A) without and (B) with color Doppler.
There is increased wall thickness with signiﬁcant dilation of the AoR (C) and
AAo (D). TEE ¼ transesophageal echocardiography; other abbreviations as in
Figure 4.
Figure 17. TEE of Nocardia Aortitis With Aneurysm
Patient with persistent fevers post–coronary artery bypass grafting
(CABG). (A) Upper esophageal long-axis view of the ascending
aorta (Ao) shows a large focal aneurysm measuring 7.2 cm (double
arrow), and (B) short-axis view of the aortic arch shows focal aortic
wall thickening. (Note: pre-CABG imaging revealed no abnormality
of the ascending aorta.) TEE ¼ transesophageal echocardiography;
other abbreviations as in Figure 4.
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616strategies of luminal imaging for diagnostic and
aneurysm screening purposes in these patients who
are potentially at increased risk of nephrotoxicity due
to ureteral obstruction (28).
Echocardiography and Vascular Ultrasound
Although not primarily utilized in the diagnosis of
aortitis, TTE, TEE, abdominal ultrasound, and
peripheral vascular ultrasound provide useful infor-
mation. These modalities may demonstrate aortic
and branch vessel mural thickening, an echolucent
“halo” due to mural edema, and aortic aneurysm
(33). Furthermore, Doppler assessment provides
functional evaluation of stenotic segments, which
may guide management. Importantly, echocardiog-
raphy is widely used for identifying complications
such as aortic root dilation and aortic valve insufﬁ-
ciency, as well as secondary myocardial dysfunction.
Echocardiography, speciﬁcally high-resolution TEE,
may also identify aortitis complications such as
aortic dissection, intramural hematoma, and pene-
trating ulcer (64). Newer 3-dimensional TTE and
TEE technology provides high-resolution real-time
renderings of aortic root and aortic valve anatomy
that may be useful for identiﬁcation of complications
and surgical planning (65,66). TTE and abdominal
ultrasound may be useful in screening for ascending
thoracic and abdominal aortic aneurysm, respectively
(67). These modalities beneﬁt from portability,
widespread availability, and lack of ionizing radia-
tion. The drawbacks include inability to image
through bone and air (prohibiting comprehensive
evaluation of thoracic aorta); operator dependence;
and difﬁcult tissue characterization, as ﬁbrosis, false
lumen, and hematoma all appear echolucent and
may be difﬁcult to differentiate (58,68).
Vascular ultrasonography ﬁndings may be useful
for the diagnosis of extracranial giant cell arteritis,
Takayasu arteritis, and idiopathic aortitis variants
with periaortitis. Classic giant cell arteritis may be
diagnosed by a “halo” sign in the temporal arteries (16);
furthermore, the extracranial “halo” sign seen in the
aorta, subclavian, axillary, and iliac arteries corre-
sponds with ﬂuorine-18-ﬂuorodeoxyglucose uptake
on PET in these regions of affected giant cell
arteritis patients (69). Takayasu arteritis can present
with more pronounced and extensive concentric
thickening of affected aorta and/or branch vessels,
with a more heterogeneous and often brighter
appearance (known as the “macaroni” sign) when
compared with the “halo” of giant cell arteritis (33)
(Fig. 14). Idiopathic aortitis variants present as
mural thickening with an echolucent periaortic
Figure 18. TEE of Staphylococcus Aureus Aortitis With
Pseudoaneurysm
Incidental ﬁnding in the setting of bacteremia and valvular
endocarditis. (A) Lower esophageal long-axis view of the abdom-
inal aorta demonstrates aortic lumen (Lum) and cavity (Cav)
separated by a neck (white arrow). (B) Lower esophageal short-
axis view of the abdominal aorta demonstrates the “double barrel”
appearance of aortic lumen and cavity. (C) Lower esophageal
short-axis view of the abdominal aorta with color Doppler showing
bidirectional ﬂow in the neck (green arrow). TEE ¼ trans-
esophageal echocardiography.
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617mass, which may be difﬁcult to differentiate from
dissection or hematoma (44). A proposed aneurysm
screening method of abdominal ultrasound, chest
radiography, and TTE has been proposed as an
alternative to CT/CTA in order to limit radiation
exposure (22).
Aortic root inﬂammation can cause mural thick-
ening, dilation, valvulitis, and aortic valve insufﬁ-
ciency as seen on TTE (Figs. 15 and 16) in a variety
of infectious and noninfectious aortitides (2,44).
Speciﬁc echocardiographic ﬁndings have been
described, such as a nodular appearance of the aortic
valve with ankylosing spondylitis-related valvulitis(60) and redundant aortic valve cusps with prolapse,
vegetation-like masses, and echolucencies with
Behcet’s valvulitis (70). These considerations may
be of paramount importance, such as in the case
of Behcet’s valvulitis, in which prosthetic aortic
valve replacements often dehisce if no pre-operative
immunosuppression is provided, and total root
replacement, with a homograft or conduit, may
provide more durable results (70). In other cases,
pre-operative TEE may demonstrate aortic valve
insufﬁciency due to commissural separation from
aortic root dilation rather than valvulitis, which
may improve with root replacement or aortic
valve repair, thus avoiding prosthetic aortic valve
replacement.
TEE may be especially helpful in the diagnosis of
infectious aortitis (Fig. 17). An atherosclerotic nidus
is often identiﬁed, and aortic mural thickening with
fusiform aneurysms, saccular aneurysms, and ulcer-
ation with pseudoaneurysm and thrombus have
been described. One or more focal echolucencies
may represent abscess cavities, in which the short-
axis views demonstrate a “double barrel” appear-
ance of the cavity adjacent to the true aortic lumen,
and the long-axis views may demonstrate a patent
“neck” connecting the true lumen to the cavity, as
seen by color Doppler (71) (Fig. 18). TEE is also
the gold standard for imaging endocarditis and pre-
operative aortic valve, aortic root, and ascending
aortic morphology for pre-operative planning in
those with infectious aortitis (72,73).Summary
Multiple modalities provide different and often
complementary imaging ﬁndings among a wide
array of aortitis presentations and potential com-
plications. PET is the most sensitive test for early
vessel inﬂammation; however, it requires CT
or MR imaging for anatomic localization. CT
provides excellent anatomical characterization of
structural aortic changes, but is limited in its
assessment of early disease activity. MR provides
characterization of both early inﬂammatory vessel
changes and late structural changes, as well as
dedicated cardiac and valvular assessment. Ultra-
sound and echocardiography provide both an-
atomical and physiologic information regarding
vessel and valvular abnormalities.
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